Back to Trades
LaBrosse Nicole
SVPCHIEF FINANCIAL OFFICERCIK 0001910662
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, LaBrosse Nicole, SVP, CHIEF FINANCIAL OFFICER, has disclosed $3.5M in transactions — all concentrated in HALOZYME THERAPEUTICS, INC. (HALO). Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.7M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Feb 24 | HALO HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Exercise | $459.0K |
| Feb 17 | HALO HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Exercise | $1.0M |
| Feb 11 | HALO HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Award | $0 |
| Sep 23 | HALO HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | Insider | Sell | $173.6K |
| Sep 11 | HALO HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | Insider | Sell | $1.5M |
5 filings